title: Asenapine once daily versus twice daily: impact on patient acceptance in a randomized, open-label, 14-day clinical trial.
authors.affiliation: xsun3@nshs.edu.
authors.forename: Xiaowei
authors.initials: X
authors.lastname: Sun
authors.forename: Robert
authors.initials: R
authors.lastname: Hamer
authors.forename: Joseph
authors.initials: J
authors.lastname: McEvoy
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003986:Dibenzocycloheptenes; D005260:Female; D006576:Heterocyclic Compounds, 4 or More Rings / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D012559:Schizophrenia / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D003986:Dibenzocycloheptenes; D006576:Heterocyclic Compounds, 4 or More Rings; C522667:asenapine